Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cambrex Corp (NYSE:CBM)

54.04
Delayed Data
As of Jan 20
 +0.04 / +0.07%
Today’s Change
29.50
Today|||52-Week Range
59.41
+0.17%
Year-to-Date

Today’s Trading

Previous close54.00
Today’s open54.05
Day’s range53.45 - 54.85
Volume329,404
Average volume (3 months)307,887
Market cap$1.7B
Dividend yield--
Data as of 4:02pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)-2.76%
Earnings growth (this year)+15.67%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+15.67%
P/E ratio26.5
Price/Sales3.54
Price/Book5.53

Competitors

 Today’s
change
Today’s
% change
PRTAProthena Corporation...+0.90+1.84%
AGIOAgios Pharmaceutical...+0.25+0.59%
SRPTSarepta Therapeutics...-1.57-4.59%
HCMHutchison China Medi...+0.06+0.43%
Data as of 4:00pm ET, 01/20/2017

Financials

Next reporting dateFebruary 14, 2017
EPS forecast (this quarter)$1.05
Annual revenue (last year)$433.3M
Annual profit (last year)$57.2M
Net profit margin13.19%

Profile

Sector
Process Industries
Industry
Chemicals: Specialty
President, Chief Executive Officer &
Director
Steven M. Klosk
Chief Operating Officer &
Executive Vice President
Shawn P. Cavanagh
Corporate headquarters
East Rutherford, New Jersey

Forecasts


Search for Jobs